A Review of Next-Generation Therapeutics and Contemporary Management of Myelofibrosis

Learn from expert faculty as they discuss recent and emerging data in myelofibrosis in a downloadable slideset from a satellite symposium and an on-demand webcast.

Share

Program Content

Activities

MF Diagnosis and Risk
Myelofibrosis: Diagnosis and Spectrum, Symptom Assessment, and Prognosis
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 09, 2022

Expires: December 08, 2023

Frontline MF Treatment
Managing Patients With Newly Diagnosed Myelofibrosis
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 09, 2022

Expires: December 08, 2023

Later-line MF Treatment
Managing Patients With Myelofibrosis and First-line Treatment Failure
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 09, 2022

Expires: December 08, 2023

<i>EP</i>: MF Management
ExpressPoints:
Next-Generation Therapeutics and Contemporary Management of Myelofibrosis
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 16, 2022

Expires: December 15, 2023

Activities

Myelofibrosis Management
A Review of Next-Generation Therapeutics and Contemporary Management of Myelofibrosis
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: December 20, 2022

Expires: December 19, 2023

Faculty

cover img faculity

Srdan Verstovsek, MD, PhD

Professor
Division of Cancer Medicine
Department of Leukemia
The University of Texas MD Anderson Cancer Center
Houston, Texas

cover img faculity

Brady L. Stein, MD, MHS

Professor of Medicine
Department of Hematology/Oncology
Northwestern University Feinberg School of Medicine
Chicago, Illinois

cover img faculity

Abdulraheem Yacoub, MD

Professor
The Division of Hematologic Malignancies and Cellular Therapeutics
University of Kansas Medical Center
The University of Kansas Health System
Westwood, Kansas

Provided by

ProCE Banner

Supporters

Supported by educational grants from

AbbVie Inc.

CTI BioPharma Corp